Literature DB >> 15564718

Marginal zone B cell physiology and disease.

Thiago Lopes-Carvalho1, John F Kearney.   

Abstract

Mature B lymphocytes do not constitute a homogenous pool of cells, and it is now clear that several functionally and developmentally distinct subsets exist. Of these, marginal zone (MZ) B cells are a subset of peripheral B cells that respond vigorously to blood-borne infections, and play a vital role, particularly in host survival of infection by encapsulated bacteria. Their fast activation and differentiation to antibody-secreting plasma cells allows MZ B cells to bridge the gap between innate and adaptive immunity, effected mainly by the more prolific follicular B cells. Like other naturally activated lymphocytes, MZ B cells may also play a role in homeostasis and tolerance, apart from combating infection. Here we will review some of the extracellular signals that affect their development, selection and function. We conclude by examining how their repertoire, location and interactions with other cell types may be important in the induction of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15564718     DOI: 10.1159/000082100

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  13 in total

1.  A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens.

Authors:  Vishal J Sindhava; Michael A Oropallo; Krishna Moody; Martin Naradikian; Lauren E Higdon; Lin Zhou; Arpita Myles; Nathaniel Green; Kerstin Nündel; William Stohl; Amanda M Schmidt; Wei Cao; Stephanie Dorta-Estremera; Taku Kambayashi; Ann Marshak-Rothstein; Michael P Cancro
Journal:  J Clin Invest       Date:  2017-03-27       Impact factor: 14.808

2.  Follicular B cell trafficking within the spleen actively restricts humoral immune responses.

Authors:  Kristen L Hoek; Laura E Gordy; Patrick L Collins; Vrajesh V Parekh; Thomas M Aune; Sebastian Joyce; James W Thomas; Luc Van Kaer; Eric Sebzda
Journal:  Immunity       Date:  2010-08-05       Impact factor: 31.745

3.  Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Authors:  Marianne A Bryan; Siobhan E Guyach; Karen A Norris
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

Review 4.  Prolactin, systemic lupus erythematosus, and autoreactive B cells: lessons learnt from murine models.

Authors:  Subhrajit Saha; Arlene Tieng; K Peter Pepeljugoski; Gisele Zandamn-Goddard; Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

5.  Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus.

Authors:  Stephen H Clarke
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 6.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

7.  Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Authors:  Edilberto Postól; André Meyer; Fabíola Cardillo; Raquel de Alencar; Daniel Pessina; Jorge Nihei; Mário Mariano; José Mengel
Journal:  Immunology       Date:  2008-04-07       Impact factor: 7.397

8.  B-cell tolerance in transplantation: is repertoire remodeling the answer?

Authors:  Ronald F Parsons; Kumar Vivek; Robert R Redfield; Thi-Sau Migone; Michael P Cancro; Ali Naji; Hooman Noorchashm
Journal:  Expert Rev Clin Immunol       Date:  2009-11       Impact factor: 4.473

9.  Reduced B lymphoid kinase (Blk) expression enhances proinflammatory cytokine production and induces nephrosis in C57BL/6-lpr/lpr mice.

Authors:  Elizabeth M Samuelson; Renee M Laird; Amber M Papillion; Arthur H Tatum; Michael F Princiotta; Sandra M Hayes
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

10.  The endocytic adaptor Eps15 controls marginal zone B cell numbers.

Authors:  Benedetta Pozzi; Stefania Amodio; Caterina Lucano; Anna Sciullo; Simona Ronzoni; Daniela Castelletti; Thure Adler; Irina Treise; Ingrid Holmberg Betsholtz; Birgit Rathkolb; Dirk H Busch; Eckhard Wolf; Helmut Fuchs; Valérie Gailus-Durner; Martin Hrabě de Angelis; Christer Betsholtz; Stefano Casola; Pier Paolo Di Fiore; Nina Offenhäuser
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.